Drugs da Cataract Risk

Ta yaya Wasu Magunguna suka bar Ka Ƙari Mai Lalacewa don Lalacewar Mutum daga Sun

Kamar yadda wasu takardun magani da magungunan ƙwayoyi zasu iya bar fata kafi karin haske - wato, mafi saukin kamuwa da lalacewa daga hasken ultraviolet na rana - wasu kwayoyi na iya kara yawan hadarin ido .

Duk da haɗari na matsalolin ido na rana mai zuwa kamar su cataracts , da shekarun da suka shafi shekaru fiye da shekaru , har ma da cututtuka kamar kwayoyin halitta, kawai rabin rabin Amirkawa suna da masaniya game da hadarin, kamar yadda Cibiyar Nazarin Ophthalmology ta Amirka (AAO) ta yi.

A shekara ta 2014 kamfanonin likita da likitocin likitocin sun fito da kuri'un da aka nuna cewa kashi 49 cikin dari na tsofaffi da aka bincika ba su sani ba ko basu yarda cewa wasu magungunan za su iya barin su ba saboda rashin lahani daga rana.

Cataracts da tsufa: Tsarin cataracts - watsi da hankali na idon idon ido - abu ne na dabi'a yayin da muka tsufa, in ji Stephanie Marioneaux, masanin ophthalmologist da kuma malaman injin.

"Cataracts za su ci gaba a cikin kowane mutum da yake rayuwa tsawon lokaci," in ji ta. "Yawanci, yana da saurin tsufa da ke faruwa a kowacce kowa.Yayinda wasu halayen haɗari kamar shan taba , amfani da steroid da tarihin iyali suna da rawar, cataracts suna da nasaba da hangen nesa daga rana kuma lalacewa zai iya faruwa wanda ba ku sani ba. "

Lalle ne, Marioneaux yayi kashedin cewa hotunan idanu na idanu baya nufin rana ta fi haske lokacin da kake waje; a maimakon haka, idanunsu sun fi sauƙi ga haskoki na hasken ultraviolet.

Wadanne kwayoyi ne hotuna? Bisa ga binciken da aka buga a 2009 a jarida Pharmacoepidemiology and Drug Safety, akwai fiye da magungunan magani 140 da aka sani don haifar da hotuna.

Ƙungiyar Ciwon Kankara ta {asar Amirka ta wallafa jerin magungunan da zai iya haifar da hasken rana a cikin rahotonta na Hotuna.

Wadannan sun hada da takardun magani da yawa waɗanda suka saba amfani dashi:

Kara karantawa: Yadda za a gudanar da magunguna daban-daban a amince

Yadda za a kare kullunku daga lalacewa na gaba: Idan kana shan duk wani magungunan hoto, hanyar da ta fi dacewa kuma mafi sauki don kauce wa matsalolin ido a nan gaba kamar cataracts da ciwon daji shine saka kayan tabarau wanda ke ba da cikakken launi. Wannan yana nufin an yi tabarau don ɗaukar 100% na UVA da UVB haskoki, da hana haske daga ultraviolet ta hanyar bugawa da ruwan tabarau, macula da retina cikin ido.

"Ba za ku iya gaya kawai ta hanyar kallon wani nau'i na tabarau ba ko suna bada wannan kariya," bayanin marioneaux. "Dark da launi na ruwan tabarau basu gaya maka kome game da shafukan UV ba; dole ne ka nemi shi akan lakabin."

Watch for "100% UV Protection", ko "UV400", dukansu biyu suna kwatanta ɗaukar hoto masu yawa, kuma suna sa tauraronka har ma a cikin yanayi mai ban tsoro kamar yadda haske na UV zai iya shiga cikin girgije.

Bayan saka takalma, za ka iya hana lalatawar launi ta hanyar ta hanyar:

Bayan haka, in ji Marioneaux, kare kullunku daga haskoki na rana shine sananne ne don kare matsalolin idanu na gaba.

"Har yanzu ba mu da wannan amsa ta salon rayuwa game da dalilin da yasa wasu suka shiga kasuwa a baya ko baya," inji ta. "Ba za mu iya tantance tasirin UV ba tukuna, amma har yanzu muna ba da shawara ga mutane don kauce wa cikakken shawarwa da kuma sa 100% UV protection, ba kawai don kauce wa cataracts - abin da zai faru duk da haka - amma don melanoma da shekaru related Macular degeneration da. "

Sources:

Facts Game da Cataract. Ƙungiyar Bayar da Bayanin Gida ta {asa na {asar Amirka. Samun damar Mayu 30, 2014.
https://www.nei.nih.gov/health/cataract/cataract_facts.asp

Bayanan Labarai: Magunguna. Ƙarin Bayanin Labarai na Ƙunƙasar Cutar Ƙunƙasar Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙunƙasa don isa ga Mayu 30,
http://www.skincancer.org/publications/photosensitivity-report/medications

Verdel BM, Sauran PC, Meyboom RH, Kardaun SH, Leufkens HG, Egberts AC. "Rashin ƙwaƙwalwar hotuna ta hanyar yin amfani da miyagun ƙwayoyi: mayar da hankali kan nau'ikan siffofin spectroscopic da kwayoyin." Pharmacoepidemiol Drug Saf . 2009 Yuli; 18 (7): 602-9.